These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37753706)

  • 1. Diabetes and Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure: An Extended Follow-Up Analysis of DANISH.
    Doi SN; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Rørth R; Kristensen SL; Bruun NE; Gustafsson F; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Butt JH
    Circ Heart Fail; 2023 Oct; 16(10):e010606. PubMed ID: 37753706
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial.
    Butt JH; Yafasova A; Doi SN; Nielsen JC; Haarbo J; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Hassager C; Svendsen JH; Høfsten DE; Videbæk L; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
    Circulation; 2023 Oct; 148(15):1179-1181. PubMed ID: 37812653
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimated Glomerular Filtration Rate and Implantable Cardioverter-Defibrillator in Nonischemic Systolic Heart Failure: Extended Follow-Up of DANISH.
    Doi SN; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Yafasova A; Bruun NE; Gustafsson F; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Butt JH
    J Am Heart Assoc; 2024 Feb; 13(3):e031977. PubMed ID: 38293926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT-proBNP and ICD in Nonischemic Systolic Heart Failure: Extended Follow-Up of the DANISH Trial.
    Butt JH; Yafasova A; Elming MB; Dixen U; Nielsen JC; Haarbo J; Videbæk L; Korup E; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
    JACC Heart Fail; 2022 Mar; 10(3):161-171. PubMed ID: 35241243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure According to Sex: Extended Follow-Up Study of the DANISH Trial.
    Butt JH; Yafasova A; Elming MB; Dixen U; Nielsen JC; Haarbo J; Videbæk L; Korup E; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
    Circ Heart Fail; 2022 Sep; 15(9):e009669. PubMed ID: 35942877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure.
    Rørth R; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Bruun NE; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Kristensen SL
    Europace; 2019 Aug; 21(8):1203-1210. PubMed ID: 31323662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of Heart Failure and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Thøgersen AM; Videbæk L; Bruun NE; Eiskjær H; Haarbo J; Egstrup K; Gustafsson F; Hastrup Svendsen J; Høfsten DE; Pehrson S; Nielsen JC; Køber L; Thune JJ
    Circ Heart Fail; 2019 Sep; 12(9):e006022. PubMed ID: 31500444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right Ventricular Dysfunction and the Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Hammer-Hansen S; Voges I; Nyktari E; Raja AA; Svendsen JH; Pehrson S; Signorovitch J; Køber LV; Prasad SK; Thune JJ
    Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007022. PubMed ID: 30866666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Olesen LL; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Thune JJ
    Circulation; 2017 Nov; 136(19):1772-1780. PubMed ID: 28877914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure.
    Nomoto M; Suzuki A; Shiga T; Shoda M; Hagiwara N
    BMC Cardiovasc Disord; 2022 Aug; 22(1):374. PubMed ID: 35974317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality).
    Yafasova A; Butt JH; Elming MB; Nielsen JC; Haarbo J; Videbæk L; Olesen LL; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Egstrup K; Gustafsson F; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
    Circulation; 2022 Feb; 145(6):427-436. PubMed ID: 34882430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH Trial.
    Kristensen SL; Levy WC; Shadman R; Nielsen JC; Haarbo J; Videbæk L; Bruun NE; Eiskjær H; Wiggers H; Brandes A; Thøgersen AM; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Signorovitch J; Køber L; Thune JJ
    JACC Heart Fail; 2019 Aug; 7(8):717-724. PubMed ID: 31302052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right Ventricular Free Wall Strain and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Jensen DH; Winsløw UC; Risum N; Butt JH; Yafasova A; Haarbo J; Philbert BT; Svendsen JH; Pehrson S; Køber L; Thune JJ
    J Card Fail; 2023 Jun; 29(6):883-892. PubMed ID: 36708755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
    Køber L; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Korup E; Jensen G; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S;
    N Engl J Med; 2016 Sep; 375(13):1221-30. PubMed ID: 27571011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Thune JJ; Pehrson S; Nielsen JC; Haarbo J; Videbæk L; Korup E; Jensen G; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Egstrup K; Hastrup-Svendsen J; Høfsten DE; Torp-Pedersen C; Køber L
    Am Heart J; 2016 Sep; 179():136-41. PubMed ID: 27595688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?
    Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton AE; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders GD
    Int J Cardiol; 2014 Mar; 172(1):253-4. PubMed ID: 24467982
    [No Abstract]   [Full Text] [Related]  

  • 19. Update of implantable cardioverter/defibrillator and cardiac resynchronization therapy in heart failure.
    Rami T; Shih HT
    Curr Opin Cardiol; 2004 May; 19(3):264-9. PubMed ID: 15096960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Mellitus and Outcomes of Cardiac Resynchronization With Implantable Cardioverter-Defibrillator Therapy in Older Patients With Heart Failure.
    Echouffo-Tcheugui JB; Masoudi FA; Bao H; Spatz ES; Fonarow GC
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27489243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.